文献速递头痛与眩晕

复发性良性阵发性位置性眩晕自我治疗的效果:一项随机临床试验

Effect of Self-treatment of Recurrent Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2023-01-01

这项在韩国多家转诊型大学医院开展的随机、对照、平行组、双盲试验纳入585例已诊断并治疗过的良性阵发性位置性眩晕(BPPV)患者,随机分入治疗组(292例)和对照组(293例),随访至少2年。治疗组在眩晕复发时通过问卷诊断并接受相应视频指导自行实施耳石复位法(CRM),对照组仅按入组时诊断类型接受视频指导。意向性分析显示,治疗组58例中42例(72.4%)报告眩晕缓解,对照组70例中30例(42.9%)报告缓解(χ2检验:95%CI 0.13-0.46;P<.001)。

要点

  • 治疗组复发时经问卷诊断后按BPPV类型接受视频指导自行CRM。
  • 治疗组58例中42例(72.4%)眩晕缓解,对照组70例中30例(42.9%)缓解(P<.001)。
  • 作者认为该系统可能对前庭疾病的远程医疗发挥作用。

核心结论

  • 该试验证明基于网络的系统对复发性BPPV的诊断和治疗有效。
  • 作者认为使用该系统可能在前庭疾病的远程医疗中发挥重要作用。

研究设计与样本

  • 随机、对照、平行组、双盲试验,在韩国多家转诊型大学医院开展,时间为2017年7月至2020年2月。
  • 728例年龄≥20岁、已诊断并治疗过BPPV的患者中,排除143例拒绝参与、无法使用互联网、有脊柱问题、多管型BPPV或认知功能障碍者后,585例入组。
  • 患者按1:1随机分入治疗组(292例,平均[SD]年龄60.3[12.8]岁,37例[64%]女性)和对照组(293例,平均[SD]年龄61.1[13.2]岁,50例[71%]女性)。
  • 患者随访复发至少2年,至2022年2月。

主要发现

  • 共有128例(21.9%)复发,其中治疗组58例、对照组70例。
  • 109例(85.2%)成功使用了基于网络的系统。
  • 意向性分析中,治疗组58例中42例(72.4%)报告眩晕缓解,对照组70例中30例(42.9%)报告缓解(χ2检验:95%CI 0.13-0.46;P<.001)。

关键数值与推荐

  • 主要结局为CRM后自报位置性眩晕缓解,采用意向性分析和符合方案分析两种方法。
  • 次要结局包括使用该程序的困难与所需协助,以及CRM相关的跌倒或其他不良事件。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo with frequent recurrences. OBJECTIVE: To determine the efficacy of a web-based diagnosis and treatment of BPPV when it recurs in patients with confirmed and treated BPPV. DESIGN, SETTING, AND PARTICIPANTS: This randomized, controlled, parallel-group, double-blind trial took place in multiple referral-based university hospitals in South Korea between July 2017 and February 2020. Of 728 patients (age ≥20 years) with diagnosed and treated BPPV, 585 were enrolled after excluding 143 who declined participation, could not use the internet, or had spinal problems, multicanal BPPV, or cognitive dysfunction. Patients were followed up for recurrence at least for 2 years until February 2022. INTERVENTIONS: Patients were randomly assigned (1:1) to the treatment or control group. The patients in the treatment group completed a questionnaire for diagnosis and received a video clip for self-administration of canalith repositioning maneuver (CRM) according to the type of BPPV diagnosed when they experienced positional vertigo again. Patients in the control group received a video clip for self-administration of CRM according to the type of BPPV that had been diagnosed on enrollment. MAIN OUTCOMES AND MEASURES: The primary outcome was self-reported resolution of positional vertigo post-CRM. Secondary outcomes included difficulties and requirement for assistance when using the program and any falls or other adverse events related to CRM. The primary outcome was analyzed using both intention-to-treat and per-protocol methods. RESULTS: Of 585 patients enrolled, 292 were randomized to the treatment group (mean [SD] age, 60.3 [12.8] years, 37 [64%] women) and 293 were randomized to the control group (mean [SD] age, 61.1 [13.2] years; 50 [71%] women). Overall, 128 (21.9%) had recurrence (58 in the treatment group and 70 in the control group), and 109 (85.2%) successfully used the web-based system. In the intention-to-treat analysis, 42 of 58 individuals (72.4%) in the treatment group and 30 of 70 individuals (42.9%) in the control group reported vertigo resolution (χ2 test: 95% CI, 0.13-0.46; P < .001). CONCLUSIONS AND RELEVANCE: This trial proved the efficacy of a web-based system for the diagnosis and treatment of recurrent BPPV. Use of this system may play an important role in telemedicine for vestibular disorders. TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0002364.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Kim HJ, Kim JS, Choi KD, et al. Effect of Self-treatment of Recurrent Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial. JAMA Neurol. 2023. PMID: 36648931. doi:10.1001/jamaneurol.2022.4944

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。